|
|
|
| home > white papers > Tightening Your Supply Chain Against Counterfeits - World Courier |
|
|
 WHITE PAPERS |
|
World Courier
|
|
Tightening Your Supply Chain Against Counterfeits
|
|
As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters.
While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link.
How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Dempsey Demystifies Regulatory Cycle at DIA Europe
March 22, 2018 (Hartford, Conn.) – RWS Life Sciences Managing Director,
Sheena Dempsey, will present “Demystifying the Multilingual Complexities
in the Regulatory Cycle” at DIA Europe 2018, on April 17, at 3:30PM
(CET), in Basel, Switzerland.
More info >> |
|
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
 |
Industry Events |
 |
BioTrinity 2018
23-25 April 2018, Novotel London West in Hammersmith
BioTrinity
2018 is taking place from 23-25 April at the Novotel London West in
Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering
and investment conference in Europe, and is a must attend event for R&D
companies, TTO’s and academia who are looking to meet, collaborate, partner and
seek funding from Big Pharma, Investors and Associated Industry companies.
More info >> |
|
|
|
